Related Experiment Videos

Alpha 1-proteinase inhibitor is a neutrophil chemoattractant after proteolytic inactivation by macrophage elastase

M J Banda1, A G Rice, G L Griffin

  • 1Laboratory of Radiobiology and Environmental Health, University of California, San Francisco 94143.

Insights

Proteolytically inactivated human alpha 1-proteinase inhibitor (alpha 1-PI) acts as a potent neutrophil attractant. This inflammatory mediator activity stems from molecular rearrangement, not fragment release.

Area of Science:

  • Biochemistry
  • Immunology
  • Protease activity

Background:

  • Human alpha 1-proteinase inhibitor (alpha 1-PI) is a key regulator of protease activity.
  • Metalloproteinases, like mouse macrophage elastase, can inactivate alpha 1-PI.
  • The biological consequences of alpha 1-PI inactivation are not fully understood.

Purpose of the Study:

  • To investigate the biological activity of alpha 1-PI after inactivation by mouse macrophage elastase.
  • To determine if inactivated alpha 1-PI can modulate neutrophil behavior.
  • To identify the specific component responsible for any observed activity.

Main Methods:

  • Incubation of human alpha 1-PI with mouse macrophage elastase.
  • Assessment of neutrophil chemotaxis using inactivated alpha 1-PI and its fragments.
  • Purification and characterization of alpha 1-PI fragments.

Main Results:

  • Proteolytic inactivation of alpha 1-PI by mouse macrophage elastase generates chemotactic activity for human neutrophils at nanomolar concentrations.
  • The chemotactic response is comparable to that induced by formyl-methionyl-leucyl-phenylalanine.
  • The Mr = 4,200 fragment of inactivated alpha 1-PI mediates the chemotactic activity, although fragments remain associated.

Conclusions:

  • Proteolytically inactivated alpha 1-PI, not native alpha 1-PI, functions as a potent chemoattractant for neutrophils.
  • The inflammatory mediator role of inactivated alpha 1-PI is attributed to a conformational change or molecular rearrangement within the inhibitor molecule.
  • These findings highlight a novel mechanism of inflammation mediated by modified proteinase inhibitors.

Related Concept Videos